編號 |
論文題目 |
期刊名稱 |
作者 |
1 |
Impact of overlapping functional gastrointestinal disorders on the quality of life in patients with gastroesophageal reflux disease |
Journal of Neurogastroenterology and Motility |
第一作者:李少武
通訊作者:張繼森 |
2 |
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial |
LANCET INFECTIOUS DISEASES |
第一作者:許耀峻
通訊作者:林肇堂
共同作者:李騰裕 |
3 |
Reply. Dr Chuang and his colleagues raised concerns about the design and definitions of our study |
Clinical Gastroenterology and Hepatology |
第一作者:李騰裕
通訊作者:吳俊穎 |
4 |
Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy. |
Journal of Clinical Medicine |
第一作者:林穎正
通訊作者:楊勝舜
通訊作者:陳一銘 |
5 |
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization |
MEDICINE |
第一作者:李少武
通訊作者:李少武 |
6 |
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease |
JOURNAL OF VIRAL HEPATITIS |
第一作者:蔡炘儒
通訊作者:李騰裕 |
7 |
Hepatitis C virus-induced exosomal microRNAs and TLR7 polymorphism regulate B-cell activating factor |
mBio |
第一作者:廖采苓
通訊作者:楊勝舜 |
8 |
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation |
Journal of Clinical Medicine |
第一作者:賴佳業
通訊作者:李騰 |
9 |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment. |
Alimentary Pharmacology & Therapeutics |
第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜 |
10 |
Anchoring of fully covered self-expandable metal stents: selected patients or all? |
ENDOSCOPY |
第一作者:廖苡君
通訊作者:彭彥鈞 |
11 |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. |
LIVER INTERNATIONAL |
第一作者:陳啟益
第一作者:黃釧峰
通訊作者:余明隆
通訊作者:林漢傑
共同作者:楊勝舜 |
12 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. |
Hepatology International |
第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜
共同作者:張崇信
共同作者:黃儀倢 |
13 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan. |
Infectious Diseases and Therapy |
第一作者:鄭斌男
通訊作者:余明隆
共同作者:楊勝舜 |
14 |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan. |
Scientific Reports |
第一作者:黃釧峰
通訊作者:余明隆
共同作者:楊勝舜 |
15 |
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis. |
Clinical and Molecular Hepatology |
第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜 |
16 |
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. |
Viruses |
第一作者:洪濬銘
通訊作者:陳培哲
共同作者:楊勝舜 |
17 |
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C. |
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION |
第一作者:徐士哲
通訊作者:莊萬龍
共同作者:楊勝舜 |
18 |
Advances in the era of direct-acting antivirals for hepatitis C in patients with unresectable hepatocellular carcinoma. |
Dig Dis. |
第一作者:陳立書
通訊作者:李騰裕 |